HIGHLIGHTS
- who: Wilson Alfredo Rios and colleagues from the , Mutations in Hepatocellular Carcinomas from Colombia have published the paper: Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia, in the Journal: (JOURNAL) of 23/03/2011
- what: The authors report that the HBV biomarker was detectable in 58.1% of the cases and the HCV biomarker in 37%. The authors report two point mutations, G12457T (exon 5) and G13804A (exon 8), located in the p53 DNA-binding domain. In this study, the mutations were described in two HCC cases (2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.